Research & development
-
Discover innovation at Chemspec Europe 2026
Are you ready to explore the future of fine and specialty chemicals? Chemspec Europe 2026, happening on 6 and 7 May at Koelnmesse, Cologne, is the ultimate destination for industry professionals.
-
Vytrus Biotech pushes boundaries in regenerative skincare
Discover how Vytrus Biotech is redefining regenerative skincare with next‑gen actives born from advanced plant biotechnology. Explore the science, performance data, and what this breakthrough means for formulators seeking efficacy, sustainability, and differentiation.
-
Chemspec Europe 2026: A premier event for the chemical industry
Chemspec Europe 2026 takes place 6–7 May at Koelnmesse, Cologne. Discover two stages covering trade, regulation, and net zero, plus AI-driven R&D, continuous manufacturing, green chemistry, new peer-led roundtables, and high-impact networking for leaders across fine and speciality chemicals.
-
The emotional benefits of cosmetics: Brain Impact’s AI and fMRI approach
By Abby VorsterExplore how Brain Impact Neuroscience uses AI and fMRI to measure the emotional impact of cosmetics—revealing objective signals of well-being, reward, and attachment. See in-cosmetics Global demos and real use cases that sharpen R&D, textures, and fragrances, and de-risk marketing with data-driven claims.
-
ARISE: Groundbreaking initiative by UCT and Services SETA
UCT and Services SETA have launched ARISE, a dedicated institute for African skin and hair health, product safety testing, and occupational skin research. Discover how this purpose-built facility will expand training, grow local talent, and position South Africa as a leader in African‑relevant dermatology.
-
SABPA Symposium 2026: South African botanicals in focus
Discover the latest in South African botanicals and biotech at the SABPA Symposium on 5 February 2026, Joostenberg Conference Venue, Stellenbosch (online or in-person). Hear leaders like Leana Snyders, Prof Makunga and Prof Stander on benefit sharing, testing, quality and documentation, and decentralised clinical trials.
-
Gattefossé celebrates two decades in China
Gattefossé marks 20 years in China with the opening of an upgraded Technical Centre of Excellence in Shanghai, underscoring its long-term commitment to the region. Discover how this strategic hub powers innovation in personal care and pharma as China rises from trend-follower to trailblazer.
-
SA’s breakthrough: Locally manufactured cholera vaccine
South Africa has launched clinical trials for its first locally manufactured oral cholera vaccine, a major step toward vaccine independence and stronger health security. Discover how Biovac, the SAMRC and global partners are shifting from distribution to development—and what this milestone means for Africa.
-
Society of Cosmetic Scientists extends deadline for abstract submissions for IFSCC Congress
Don’t miss your chance to showcase original research at the 32nd IFSCC Congress in London—abstract submissions are now open until 18 February. Explore cutting-edge topics in cosmetic science and present alongside global experts; submit your work today!
-
GESlabs licenced by SAHPRA to produce cannabinoid pharma ingredients
GESLabs has secured SAHPRA approval to manufacture pharmaceutical-grade cannabinoid ingredients at its new Cape Town facility, backed by R20 million in foreign investment. Discover how this world-class lab is setting new benchmarks for South Africa’s medical innovation and global export.
-
COVID-19 myths debunked
With only a quarter of South Africans fully vaccinated, tackling COVID-19 myths is more important than ever. Discover the real facts about vaccine safety and why shifting our approach is key to protecting lives and easing pressure on our healthcare system.
-
Why the pharmaceutical industry is so integral to South Africa’s prosperity
Discover how South Africa’s pharmaceutical industry powers healthcare innovation and national well-being—especially vital in the wake of COVID-19. Explore why these trusted experts are key to our country’s prosperity and ongoing health security.















